In this episode, Chrissie discuss the data sources used for pharmaceutical research and developments, the ethical issues arising with the use of data in the pharmaceutical industry, and what the future of AI looks like in the pharmaceutical industry.

About Christine Fletcher

Chrissie is the Vice President of Development Statistics at GlaxoSmithKline.  She leads a group of statisticians supporting the development of new and approved medicines in immunology, hepatology/gastrointestinal, respiratory, cardiovascular, neuroscience, HIV, global health and infectious disease areas.  Chrissie has worked in the Pharmaceutical Industry for 30 years and has experience of developing and commercializing new medicines in a variety of clinical disease areas across all phases of clinical development.  She previously worked at Amgen in a variety of leadership roles and began her career working at SmithKline Beecham.

Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry.  Chrissie is the Chair of PSI, a Council member of EFSPI, and a member of various European and International Special Interest Groups.  Chrissie is a member of the EFPIA Clinical Research Expert Group and is leading the Innovation in Clinical Trials sub team.  Chrissie is the lead EFPIA representative for the ICH E9(R1) Working Group, and she is co-leading an EFPIA/EFSPI estimand implementation working group.

Chrissie is a Chartered Statistician of the Royal Statistical Society (RSS).  Chrissie has an MSc in Applied Statistics and a BSc (Hons) in Statistics with Management Science Techniques.

Overview
The pharmaceutical industry has had many advancements thanks to data and AI. Chrissie discusses how these advancements have supported the research for vaccines during the pandemic. We spotlight the ethical problems that may arise when using data in the pharmacy industry. From her 30+ years of experience, Chrissie shares her advice for those who are looking to work in the pharmaceutical industry. She closed out the podcast by discussing what most excites her about the future of AI.


Learn more about our mission and become a member here: https://www.womenindata.org/